Find Federal Grants
Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
National Institutes of Health · RFA-MH-22-176
Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
National Institutes of Health · RFA-MH-22-175
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-22-145
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-099
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)
National Institutes of Health · RFA-DE-22-011
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
National Institutes of Health · PAR-22-058
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
National Institutes of Health · RFA-ES-22-002
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-083
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
National Institutes of Health · PAR-22-103
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-22-084
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-HD-22-024
Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
National Institutes of Health · PAR-22-102
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TR-22-013
Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HG-22-004
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MD-22-007
National Institutes of Health · PAR-22-075
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TR-22-011
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
National Institutes of Health · RFA-NS-22-037
U.S. Mission to France · PDS-FRANCE-FY2022-03
National Institutes of Health · RFA-HL-23-006